客製化重組蛋白生產服務市場：按表達系統、最終用戶和地區分類

Custom Recombinant Protein Production Services Market, By Expression System, By End User, By Region

出版日期: 2026年04月28日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，客製化重組蛋白生產服務市場規模將達到 68 億美元，到 2033 年將達到 147.6 億美元。預計 2026 年至 2033 年的複合年成長率將達到 11.7%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	68億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	11.70%	2033年市場規模預測：	147.6億美元

客製化重組蛋白生產是生命科學領域最高效的技術之一，在先進醫療保健中發揮著至關重要的作用。重組蛋白在生技、科研和醫學領域有著廣泛的應用。生命科學領域投資的增加預計將加速客製化重組蛋白生產服務市場的成長。重組蛋白在治療應用中的重要性正在顯著提升。許多生物製藥公司正致力於研發用於治療危及生命的疾病的新型生物相似藥。利用特定技術對蛋白質進行改造，即可生產重組蛋白。這些重組蛋白經過基因編碼，能夠大量生產。重組蛋白也被用來生產市售的治療產品。重組蛋白生產技術的進步預計將推動市場成長。

市場動態

預計生命科學領域資金和投資的增加將推動預測期內的市場成長。例如，英國牛津蛋白質生產設施從分子生物學研究所獲得了300萬美元的額外資助，這將為其提供一系列高度專業化的技術，包括用於重組蛋白高通量純化、表達和結晶的機器人系統。

本研究的主要特點：

本報告對客製化重組蛋白生產服務市場進行了詳細分析，提出了 2026 年至 2033 年預測期內的市場規模和複合年成長率 (CAGR%)，其中 2025 年為基準年。
本報告揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本報告根據以下參數分析了客製化重組蛋白生產服務市場的主要參與者：公司概況、產品系列、主要亮點、財務表現和策略。
本報告提供的見解將幫助企業負責人和經營團隊就未來的產品類型升級、市場擴張和行銷策略做出明智的決策。
這份「客製化重組蛋白製造服務市場」報告的目標受群眾外包括產業內的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用分析客製化重組蛋白生產服務市場中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第7章競爭情勢

公司簡介
- GenScript Biotech Corporation
- SignalChem Biotech Inc.
- Crown Bioscience, Inc.
- BPS Bioscience Inc.
- Novoprotein
- Applied Biological Materials（abm）Inc.
- Eurofins Pharma Discovery Services
- Abgent（WuXi AppTec Company）
- Kempbio, Inc.
- Trenzyme GmbH
- Sino Biological Inc.
- Aragen Bioscience, a GVKBIO Company
- LakePharma, Inc.
- Proteos Inc.
- Icosagen AS
- Novus Biological LLC
- Proteogenix
- Premas Biotech
- ATUM
- Aldevron

第8章

參考
調查方法
公司簡介 / 聯絡我們

簡介目錄

Product Code: CMI2737

Custom Recombinant Protein Production Services Market is estimated to be valued at USD 6.80 Bn in 2026 and is expected to reach USD 14.76 Bn by 2033, growing at a compound annual growth rate (CAGR) of 11.7% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 6.80 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	11.70%	2033 Value Projection:	USD 14.76 Bn

Custom recombinant protein production is one of the efficient techniques used in life sciences that play a major role in advanced healthcare. Recombinant proteins have a wide range of applications in biotechnology, research, and medicine. Increasing funding in the field of life sciences is expected to accelerate growth of the custom recombinant protein production services market. The importance of recombinant protein for therapeutic application is increasing immensely. Various biopharmaceutical companies are focusing on research and development of novel biosimilars for life threatening diseases. Proteins are manipulated using specified techniques to derive recombinant proteins, these recombinant proteins are encoded by genes for the production of large quantities of protein. Recombinant proteins are further used for the manufacturing of therapeutic commercial products. Technological advancement in the production of recombinant protein is predicted to boost growth of the market.

Market Dynamics

Increasing funding and investments in the field of life sciences are expected to drive the market growth during the forecast period. For instance, additional funding of US$ 3.0 million was received by Oxford Protein Production Facility-UK from the Laboratory of Molecular Biology for providing a wide range of highly specialized technologies that incorporates robotic systems for high throughput purification, expression, and crystallization of recombinant proteins.

Key features of the study:

The report provides an in-depth analysis of the Custom Recombinant Protein Production Services market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period 2026-2033, considering 2025 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the custom recombinant protein production services market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, strategies
Key companies covered as a part of this study include GenScript Biotech Corporation, SignalChem Biotech Inc., Crown Bioscience, Inc., BPS Bioscience Inc., Novoprotein, Applied Biological Materials (abm) Inc., Eurofins Pharma Discovery Services, Abgent (WuXi AppTec Company), OriGene Technologies, Inc., Kempbio, Inc., Trenzyme GmbH, Sino Biological Inc., Aragen Bioscience, a GVKBIO Company, LakePharma, Inc., Proteos Inc., Icosagen AS, Novus Biological LLC, Proteogenix, Premas Biotech, ATUM, and Aldevron
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The custom recombinant protein production services market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the custom recombinant protein production services market

Detailed Segmentation:

Custom Recombinant Protein Production Services Market, By Expression System (Revenue, USD Bn, 2021 - 2033)
Mammalian
Bacteria
Insect
Yeast
Others
Custom Recombinant Protein Production Services Market, By End User (Revenue, USD Bn, 2021 - 2033)
Research Institutes
Biotechnology and Pharmaceutical Companies
Contract Research Organizations
Others
Custom Recombinant Protein Production Services Market, By Region (Revenue, USD Bn, 2021 - 2033)
North America
- By Expression System
  - Mammalian
  - Bacteria
  - Insect
  - Yeast
  - Others
- , By End User
  - Research Institutes
  - Biotechnology and Pharmaceutical Companies
  - Contract Research Organizations
  - Others
- By Country
  - U.S.
  - Canada
Latin America
- By Expression System
  - Mammalian
  - Bacteria
  - Insect
  - Yeast
  - Others
- , By End User
  - Research Institutes
  - Biotechnology and Pharmaceutical Companies
  - Contract Research Organizations
  - Others
- By Country
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- By Expression System
  - Mammalian
  - Bacteria
  - Insect
  - Yeast
  - Others
- , By End User
  - Research Institutes
  - Biotechnology and Pharmaceutical Companies
  - Contract Research Organizations
  - Others
- By Country
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- By Expression System
  - Mammalian
  - Bacteria
  - Insect
  - Yeast
  - Other
- By End User
  - Research Institutes
  - Biotechnology and Pharmaceutical Companies
  - Contract Research Organizations
  - Others
- By Country
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- By Expression System
  - Mammalia
  - Bacteria
  - Insect
  - Yeast
  - Others
- , By End User
  - Research Institutes
  - Biotechnology and Pharmaceutical Companies
  - Contract Research Organizations
  - Others
- By Country
  - GCC
  - Israel
  - Rest of Middle East
Africa
- By Expression System
  - Mammalian
  - Bacteria
  - Insect
  - Yeast
  - Others
- , By End User
  - Research Institutes
  - Biotechnology and Pharmaceutical Companies
  - Contract Research Organizations
  - Others
- By Country/Region
  - South Africa
  - Central Africa
  - North Africa
Company Profiles
GenScript Biotech Corporation *
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
SignalChem Biotech Inc.
Crown Bioscience, Inc.
BPS Bioscience Inc.
Novoprotein
Applied Biological Materials (abm) Inc.
Eurofins Pharma Discovery Services
Abgent (WuXi AppTec Company)
OriGene Technologies, Inc.
Kempbio, Inc.,
Trenzyme GmbH
Sino Biological Inc.
Aragen Bioscience, a GVKBIO Company
LakePharma, Inc.
Proteos, Inc.
Icosagen AS
Novous Biologicals LLC
Proteogenix
Premas Biotech
ATUM
Aldevron

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Expression System
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Test Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Custom Recombinant Protein Production Services Market, By Expression System , 2021-2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Mammalian
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
Bacteria
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
Insect
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
Yeast
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends

5. Global Custom Recombinant Protein Production Services Market, By End User, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
Biotechnology and Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
Contract Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends

6. Global Custom Recombinant Protein Production Services Market, By Region, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
North America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Expression System , 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2021 -2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Expression System , 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2021 -2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (US$ Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Expression System , 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2021 -2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (US$ Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Expression System , 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2021 -2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (US$ Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Expression System , 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2021 -2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (US$ Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Expression System , 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2021 -2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2021 -2033, (US$ Bn)
  - North Africa
  - Central Africa
  - South Africa

7. Competitive Landscape

Company Profiles
- GenScript Biotech Corporation
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- SignalChem Biotech Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Crown Bioscience, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- BPS Bioscience Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Novoprotein
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Applied Biological Materials (abm) Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Eurofins Pharma Discovery Services
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Abgent (WuXi AppTec Company)
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Kempbio, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Trenzyme GmbH
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Sino Biological Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Aragen Bioscience, a GVKBIO Company
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- LakePharma, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Proteos Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Icosagen AS
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Novus Biological LLC
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Proteogenix
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Premas Biotech
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- ATUM
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Aldevron
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies